RT Journal Article
T1 Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae
A1 Calvo, Almudena
A1 Giménez, María José
A1 Alou Cervera, Luis
A1 Gómez-Lus Centelles, María Luisa
A1 Aguilar, Lorenzo
A1 Prieto Prieto, José
PB Elsevier
SN 0924-8579
YR 2002
FD 2002-08
LK https://hdl.handle.net/20.500.14352/107072
UL https://hdl.handle.net/20.500.14352/107072
LA eng
NO Calvo A, Giménez MJ, Alou L, Gómez-Lus ML, Aguilar L, Prieto J. Ex vivo serum activity (killing rates) after gemifloxacin 320 mg versus trovafloxacin 200 mg single doses against ciprofloxacin-susceptible and -resistant Streptococcus pneumoniae. Int J Antimicrob Agents. 2002 Aug;20(2):144-6.
DS Docta Complutense
RD 3 abr 2025